(Q35878722)

English

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

scientific article published on 17 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Marc Miravitlles

3

object named as

Marc Miravitlles

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Maureen P M H Rutten-van Mölken

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Jan B Oostenbrink

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Brigitta U Monz

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

17 March 2007

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

The European Journal of Health Economics

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

123-135

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

The impact of reducing dose frequency on health outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Chronic obstructive pulmonary disease * 12: New treatments for COPD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Time course of recovery of health status following an infective exacerbation of chronic bronchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Costs of chronic bronchitis and COPD: a 1-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Health economic guidelines--similarities, differences and some implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Handling uncertainty in cost-effectiveness models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

An introduction to Markov modelling for economic evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

11 July 2018

Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Representing uncertainty: the role of cost-effectiveness acceptability curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913175

24 September 2018

Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[What is an efficient health technology in Spain?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Description of a sample of patients with chronic obstructive pulmonary disease treated at hospital-supervised respiratory clinics at primary care centers]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NICE reference case requirement: implications for drug manufacturers and health systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

https://pubmed.ncbi.nlm.nih.gov/17370096

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10198-007-0039-4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35878722&oldid=2197904703"